Although the presence of HP, CMV and Cpn in atherosclerotic lesions is confirmed in many studies, it would be helpful if we had the opportunity to take parallel samples from affected and non-affected arteries, as well as samples from non-CAD subjects, to support the quality of our results and maybe help us clarify some of the results. The gene discussed is CPN1; the disease is coronary artery disorder.